Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems. - Wikidata - awgldk - TriplyDB

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

http://www.wikidata.org/entity/Q34548451

about

A clinician's guide to ADHD treatment options.

P2860

Q53132267-5A231AA1-7759-4BE3-8040-881DBBFF3A8E

P2860

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

http://www.wikidata.org/entity/Q34548451

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@ast

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@en

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@nl

type

label

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@ast

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@en

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@nl

prefLabel

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@ast

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@en

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@nl

P1433

Q34548451-7907B095-95BA-49F5-B892-F2CA68678AE2

P1476

Q34548451-00DE918C-028B-4298-BB1E-6C63C6414C88

P2093

Q34548451-A8260323-3305-4E83-ACC5-35B7825845ED

Q34548451-C6CE3790-39ED-4435-8912-B8697B157485

P2860

Q34548451-0A8D2707-C6C0-4E3E-A4A3-765D9D4C3ADA

Q34548451-0CE039C7-3A07-4916-A4D2-6DFCB5DE5BFA

Q34548451-0D9680A6-3F1C-4B02-B864-D63CD7D491D2

Q34548451-13FE1104-AE76-45D7-ABDA-A150B6DF6134

Q34548451-34697E08-DA6A-4C6E-9341-C96AC978845C

Q34548451-3EC649A5-52D6-4552-8DED-69B8B61E238E

Q34548451-451B9E40-4538-49CB-B59E-6AAE4410BC87

Q34548451-549899E7-A871-4B99-B37A-A9F6596C57AC

Q34548451-6C4B73E1-043B-410D-AAE0-C2B5D88D763C

Q34548451-6F0AA9AC-6D92-4B13-A833-D058C8208E4F

P304

Q34548451-7E96B515-A46C-4276-B0A8-7B7508114D0F

P31

Q34548451-3065B2A4-529F-4DAA-9C59-71A4D8C8780A

P356

Q34548451-3592E79F-6FE1-41C9-BFCF-E97225DBC43B

P433

Q34548451-711C6963-3229-43C6-89A2-406D80B8F875

P478

Q34548451-4CC103D6-C4D9-41D8-8303-497D3F8B52F1

P577

Q34548451-6391F33A-6BD6-4612-95D8-AB25BAB17E65

P698

Q34548451-7B325AFF-6599-4F03-903C-874F4A5D94D5

P356

S1092852916000808

P1433

C N S Spectrums

P1476

Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.

@en

P2093

Gregory W Mattingly

http://www.w3.org/2001/XMLSchema#string

Richard H Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Methyiphenidate vs. amphetamine: Comparative review

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

Molecular genetics of attention deficit hyperactivity disorder.

Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.

Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study.

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.

A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.

The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal.

Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers.

P304

45-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1092852916000808

http://www.w3.org/2001/XMLSchema#string

P433

S1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28044946

http://www.w3.org/2001/XMLSchema#string